Transitional Treatment of Adolescents in Family Therapy (Transitions)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Oregon Research Institute
ClinicalTrials.gov Identifier:
NCT00680381
First received: May 16, 2008
Last updated: May 22, 2013
Last verified: May 2013

May 16, 2008
May 22, 2013
January 2004
July 2014   (final data collection date for primary outcome measure)
Drug use levels for adolescents who have received family therapy and one of the three aftercare regimens [ Time Frame: pretx and 6 wks, 4 , 7 and 12 mos. post initial therapy session ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00680381 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Transitional Treatment of Adolescents in Family Therapy
Transitional Treatment of Adolescents in Family Therapy

The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.

Not Provided
Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Substance Abuse
  • Behavioral: MTI, Minimal Transitional Intervention
    Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
  • Behavioral: GTI, Group Transitional Intervention
    Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
  • Behavioral: STI, Systems Transitions Intervention
    Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.
  • Active Comparator: 1
    Following 12 weeks of Functional Family Therapy (FFT), semi-weekly therapist phone calls for eight weeks.
    Intervention: Behavioral: MTI, Minimal Transitional Intervention
  • Active Comparator: 2
    Following 12 weeks of FFT, weekly one-hour group therapy for eight weeks
    Intervention: Behavioral: GTI, Group Transitional Intervention
  • Active Comparator: 3
    Following 12 weeks of FFT, an eight-week, customized series of therapist visits with the adolescent, family, teachers, coaches and others who can support the adolescent's reduced level of drug use.
    Intervention: Behavioral: STI, Systems Transitions Intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
90
December 2014
July 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. At least one parent, step-parent, or surrogate parent willing to participate in the study
  2. 13 to 18 years if age
  3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence
  4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND
  5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria:

  1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
  2. Adolescent deemed dangerous to self or others during evaluation
  3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)
  4. Adolescent already has participated in treatment project at CFAR; AND
  5. A sibling is already participating in project.
Both
13 Years to 18 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00680381
DA15762, R01DA15762
No
Oregon Research Institute
Oregon Research Institute
Not Provided
Principal Investigator: Holly B. Waldron, Ph.D. Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)
Oregon Research Institute
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP